医学
抗血栓
心房颤动
心脏病学
内科学
冠状动脉疾病
随机对照试验
作者
Satoshi Yasuda,Koichi Kaikita,Masaharu Akao,Junya Ako,Tetsuya Matoba,Masato Nakamura,Katsumi Miyauchi,Nobuhisa Hagiwara,Kazuo Kimura,Atsushi Hirayama,Kunihiko Matsui,Hisao Ogawa
标识
DOI:10.1056/nejmoa1904143
摘要
As antithrombotic therapy, rivaroxaban monotherapy was noninferior to combination therapy for efficacy and superior for safety in patients with atrial fibrillation and stable coronary artery disease. (Funded by the Japan Cardiovascular Research Foundation; AFIRE UMIN Clinical Trials Registry number, UMIN000016612; and ClinicalTrials.gov number, NCT02642419.).
科研通智能强力驱动
Strongly Powered by AbleSci AI